Advancing Screening for Chronic Kidney Disease: The Expanding Role of Pharmacists
This program is made possible by an independent grant from Boehringer Ingleheim Pharmaceuticals, Inc. and Eli Lilly and Company.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Bepirovirsen, First ASO for Chronic Hepatitis B
2
Operationalizing Therapy and Managing Hypophosphatemia Risk at UPMC
3
FDA Grants Accelerated Approval to Ravulizumab for Proteinuria Reduction in IgA Nephropathy
4
CagriSema Tied to 25% Weight Loss in Women, Post Hoc Data Show
5